Vault-13

Eagle Health Investments LP

Greenwich, CT · CIK 1842545 · 13F filing filed 2022-08-11

SEC-registered investment adviser since 2021 · limited partnership

As an employer

$428.9m reported value +5.7% vs Q1 2022
28positions
65.0%in top 10
4 new 12 added 3 reduced 4 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SEAGEN INC COM SGEN SGEN 262,502 $46.4m10.83% 10.83% AddedShares held: Q3 2021 0, Q4 2021 80.5k, Q1 2022 230.5k, Q2 2022 262.5k +32.0k +32,000 13.9%
2 HUMANA INC COM HUM HUM 80,191 $37.5m8.75% 8.75% AddedShares held: Q3 2021 68.5k, Q4 2021 78.6k, Q1 2022 77.9k, Q2 2022 80.2k +2.3k +2,300 3.0%
3 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 159,238 $37.5m8.75% 8.75% UnchangedShares held: Q3 2021 98.0k, Q4 2021 153.4k, Q1 2022 159.2k, Q2 2022 159.2k
4 IQVIA HLDGS INC COM IQV IQV 126,095 $27.4m6.38% 6.38% AddedShares held: Q3 2021 81.2k, Q4 2021 99.6k, Q1 2022 112.0k, Q2 2022 126.1k +14.1k +14,100 12.6%
5 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 383,065 $25.3m5.90% 5.90% ReducedShares held: Q3 2021 449.6k, Q4 2021 611.7k, Q1 2022 445.7k, Q2 2022 383.1k -62.6k -62,600 -14.1%
6 ARGENX SE SPONSORED ADR ARGX ARGX 60,300 $22.8m5.33% 5.33% ReducedShares held: Q3 2021 53.6k, Q4 2021 62.3k, Q1 2022 69.9k, Q2 2022 60.3k -9.6k -9,600 -13.7%
7 ILLUMINA INC COM ILMN ILMN 119,108 $22.0m5.12% 5.12% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 119.1k
8 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 149,380 $21.8m5.08% 5.08% AddedShares held: Q3 2021 90.1k, Q4 2021 113.7k, Q1 2022 131.2k, Q2 2022 149.4k +18.1k +18,136 13.8%
9 NATERA INC COM NTRA NTRA 570,994 $20.2m4.72% 4.72% AddedShares held: Q3 2021 164.5k, Q4 2021 211.7k, Q1 2022 447.5k, Q2 2022 571.0k +123.5k +123,500 27.6%
10 DEXCOM INC COM DXCM DXCM 237,100 $17.7m4.12% 4.12% AddedShares held: Q3 2021 118.0k, Q4 2021 106.8k, Q1 2022 155.6k, Q2 2022 237.1k +81.5k +81,500 52.4%
11 INSPIRE MED SYS INC COM INSP INSP 94,153 $17.2m4.01% 4.01% AddedShares held: Q3 2021 68.7k, Q4 2021 76.3k, Q1 2022 76.3k, Q2 2022 94.2k +17.9k +17,900 23.5%
12 CANO HEALTH INC COM CL A COM CL A 3,816,712 $16.7m3.90% 3.90% AddedShares held: Q3 2021 676.4k, Q4 2021 1.9m, Q1 2022 3.0m, Q2 2022 3.8m +861.6k +861,600 29.2%
13 AMERICAN WELL CORP CL A CL A 3,741,413 $16.2m3.77% 3.77% ReducedShares held: Q3 2021 901.3k, Q4 2021 2.2m, Q1 2022 3.8m, Q2 2022 3.7m -69.6k -69,595 -1.8%
14 OUTSET MED INC COM OM OM 1,018,960 $15.1m3.53% 3.53% AddedShares held: Q3 2021 332.8k, Q4 2021 329.0k, Q1 2022 329.0k, Q2 2022 1.0m +690.0k +689,960 209.7%
15 AXONICS INC COM AXNX AXNX 256,465 $14.5m3.39% 3.39% UnchangedShares held: Q3 2021 190.4k, Q4 2021 256.5k, Q1 2022 256.5k, Q2 2022 256.5k
16 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 65,530 $13.2m3.07% 3.07% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 65.5k
17 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 576,413 $12.8m2.98% 2.98% AddedShares held: Q3 2021 235.5k, Q4 2021 431.4k, Q1 2022 431.4k, Q2 2022 576.4k +145.0k +145,000 33.6%
18 10X GENOMICS INC CL A COM TXG TXG 261,200 $11.8m2.76% 2.76% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 261.2k
19 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 1,214,860 $9.8m2.29% 2.29% AddedShares held: Q3 2021 441.5k, Q4 2021 750.8k, Q1 2022 1.0m, Q2 2022 1.2m +200.0k +200,000 19.7%
20 BLUEPRINT MEDICINES CORP COM BPMC BPMC 170,551 $8.6m2.01% 2.01% UnchangedShares held: Q3 2021 176.2k, Q4 2021 192.6k, Q1 2022 170.6k, Q2 2022 170.6k
21 GUARDANT HEALTH INC COM GH GH 151,960 $6.1m1.43% 1.43% UnchangedShares held: Q3 2021 95.7k, Q4 2021 119.4k, Q1 2022 152.0k, Q2 2022 152.0k
22 CAREMAX INC COM CL A COM CL A 714,755 $2.6m0.61% 0.61% UnchangedShares held: Q3 2021 616.8k, Q4 2021 714.8k, Q1 2022 714.8k, Q2 2022 714.8k
23 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 261,423 $1.8m0.43% 0.43% AddedShares held: Q3 2021 57.1k, Q4 2021 132.1k, Q1 2022 132.1k, Q2 2022 261.4k +129.3k +129,333 97.9%
24 BEAM THERAPEUTICS INC COM BEAM BEAM 28,900 $1.1m0.26% 0.26% UnchangedShares held: Q3 2021 0, Q4 2021 28.9k, Q1 2022 28.9k, Q2 2022 28.9k
25 ARVINAS INC COM ARVN ARVN 23,000 $968.0k0.23% 0.23% UnchangedShares held: Q3 2021 23.0k, Q4 2021 23.0k, Q1 2022 23.0k, Q2 2022 23.0k
26 LYELL IMMUNOPHARMA INC COM COM 100,000 $652.0k0.15% 0.15% UnchangedShares held: Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 100.0k, Q2 2022 100.0k
27 OLINK HLDG AB SPONSORED ADS SPONSORED ADS 40,000 $608.0k0.14% 0.14% UnchangedShares held: Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k, Q2 2022 40.0k
28 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 23,500 $394.0k0.09% 0.09% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 23.5k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
VERTEX PHARMACEUTICALS INC VRTX VRTX 82,144 $21.4m82.1k shares
MIRATI THERAPEUTICS INC MRTX MRTX 52,000 $4.3m52.0k shares
KYMERA THERAPEUTICS INC KYMR KYMR 37,000 $1.6m37.0k shares
C4 THERAPEUTICS INC CCCC CCCC 47,200 $1.1m47.2k shares